pharmaphorum February 22, 2024
Phil Taylor

The US FDA has issued a warning against the use of smartwatches or smart ring devices that claim to be able to measure blood glucose levels.

The regulator points out that there are no approved blood glucose measuring devices available yet that do not require the skin to be pierced and a sample of blood taken, and any wearable device that claims to do so on its own is unapproved and could put users at risk.

These are very different from smartwatch applications that display data from FDA-approved blood glucose measuring devices that pierce the skin, like continuous glucose monitoring devices (CGMs), it adds.

The warning applies to any smartwatch or smart ring that claims to measure blood glucose without...

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

 
Topics: Digital Health, FDA, Govt Agencies, Technology, Wearables
'We can nip a pandemic in the bud with smartwatches'
Flattening the curve: How smartwatches could help stop a pandemic before it even begins
Unlocking the power of sensor data in type 2 diabetes care
Google’s Pixel Watch 3 Loss of Pulse Detection Feature Receives FDA Clearance
10 Ways Technology is Changing Healthcare - 3

Share This Article